emodin has been researched along with schizandrin b in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, PY; Ko, KM; Mak, DH; Poon, MK | 1 |
| Jin, XD; Li, L; Li, YZ; Liu, XN; Zhang, CY; Zheng, XZ | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
3 other study(ies) available for emodin and schizandrin b
| Article | Year |
|---|---|
In vivo antioxidant action of a lignan-enriched extract of Schisandra fruit and an anthraquinone-containing extract of Polygonum root in comparison with schisandrin B and emodin.
Topics: Alanine Transaminase; alpha-Tocopherol; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyclooctanes; Emodin; Female; Fruit; Glutathione; L-Iditol 2-Dehydrogenase; Lignans; Mice; Mice, Inbred BALB C; Mitochondria, Liver; Phytotherapy; Plant Extracts; Plant Roots; Polycyclic Compounds; Polygonum; Random Allocation; Schisandra | 2002 |
Inhibitory effect of schisandrin B on gastric cancer cells in vitro.
Topics: Astragalus Plant; Cell Cycle; Cell Line, Tumor; Cyclin D1; Cyclooctanes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Emodin; Glucosides; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Lignans; Medicine, Chinese Traditional; Mitosis; Polycyclic Compounds; Polysaccharides; RNA, Messenger; Stomach Neoplasms; Time Factors | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |